Immunology
coviki.org collects the really good Ideas and the scientific Record on Covid-19 Virus.
Antibody-dependent enhancement
| 32092539 2020. Is COVID-19 receiving ADE from other coronaviruses? |
32268188 ä. It is too soon to attribute ADE to COVID-19
| 31826992 2020. Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry |
| 32317716 ä. The potential danger of suboptimal antibody responses in COVID-19 |
32346094 ä. COVID-19 vaccine design: the Janus face of immune enhancement
32303697 ä. Will we see protection or reinfection in COVID-19?
32438257 2020. SARS-CoV-2 and enhancing antibodies
| 32408068 2020. What about the original antigenic sin of the humans versus SARS-CoV-2? |
Innate sensing of infection
| 32291557 ä. SARS-CoV-2-encoded nucleocapsid protein acts as a viral suppressor of RNA interference in cells |
32198201 2020. Coronavirus endoribonuclease targets viral polyuridine sequences to evade activating host sensors
32374430 2020. DC/L-SIGNs of Hope in the COVID-19 Pandemic
32361001 ä. Bioinformatic analysis and identification of single-stranded RNA sequences recognized by TLR7/8 in the SARS-CoV-2, SARS-CoV, and MERS-CoV genomes
32248387 ä. Use of DAMPs and SAMPs as Therapeutic Targets or Therapeutics: A Note of Caution
| 32407669 ä. Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients |
nk cells
32382127 ä. NKG2A and COVID-19: another brick in the wall
integrative work
32205856 2020. COVID-19 infection: the perspectives on immune responses
32359396 ä. A Dynamic Immune Response Shapes COVID-19 Progression
C7064018 ä. Coronavirus infections: Epidemiological, clinical and immunological features and hypotheses
| C7200337 ä. Immunology of COVID-19: current state of the science |
covid modulates the immune system
32364527 2020. Immune environment modulation in pneumonia patients caused by coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2
32172672 2020. A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses
32315725 ä. Suppressed T cell-mediated immunity in patients with COVID-19: a clinical retrospective study in Wuhan, China
| 32355328 ä. Impaired interferon signature in severe COVID-19 |
32375560 2020. SARS-CoV-2-Induced Immune Dysregulation and Myocardial Injury Risk in China: Insights from the ERS-COVID-19 Study
32376308 ä. Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis
| 32236983 2020. Why the immune system fails to mount an adaptive immune response to a COVID-19 infection |
| 32286536 ä. Coronaviruses hijack the complement system |
mediators
32360285 ä. Type I IFN immunoprofiling in COVID-19 patients
| 32376393 ä. Interleukin-17A (IL-17A), a key molecule of innate and adaptive immunity, and its potential involvement in COVID-19-related thrombotic and vascular mechanisms |
| 32305501 ä. The Potential Role of Th17 Immune Responses in Coronavirus Immunopathology and Vaccine-induced Immune Enhancement |
30715745 2019. (+)Th17 serum cytokines in relation to laboratory?confirmed respiratory viral infection: A pilot study
32414693 2020. Interleukin-6 levels in children developing SARS-CoV-2 infection
plasmacytoid dendritic cells
32298486 2020. Plasmacytoid lymphocytes in SARS-CoV-2 infection (Covid-19)
immune cell subpopulations
32282871 ä. Inflammatory Response Cells During Acute Respiratory Distress Syndrome in Patients With Coronavirus Disease 2019 (COVID-19)
32325421 2020. Increased expression of CD8 marker on T-cells in COVID-19 patients
32377375 2020. Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing
32346099 ä. High-dimensional immune profiling by mass cytometry revealed immunosuppression and dysfunction of immunity in COVID-19 patients
32339487 2020. Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China
32361250 2020. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients
32228226 2020. Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients
32196410 2020. Hypothesis for potential pathogenesis of SARS-CoV-2 infection?a review of immune changes in patients with viral pneumonia
32333914 ä. A possible role for B cells in COVID-19?: Lesson from patients with Agammaglobulinemia
32344320 ä. The clinical course and its correlated immune status in COVID-19 pneumonia
32325129 ä. The profile of peripheral blood lymphocyte subsets and serum cytokines in children with 2019 novel coronavirus pneumonia
32283159 ä. Lymphocyte subset (CD4+, CD8+) counts reflect the severity of infection and predict the clinical outcomes in patients with COVID-19
32227123 ä. Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia
32343510 2020. COVID-19: are T lymphocytes simply watching?
32379887 ä. T cell subset counts in peripheral blood can be used as discriminatory biomarkers for diagnosis and severity prediction of COVID-19
32297671 2020. Relationships among lymphocyte subsets, cytokines, and the pulmonary inflammation index in coronavirus (COVID-19) infected patients
32352397 2020. The hemocyte counts as a potential biomarker for predicting disease progression in COVID-19: a retrospective study
32379199 2020. A Typical Case of Critically Ill Infant of Coronavirus Disease 2019 With Persistent Reduction of T Lymphocytes
32296069 2020. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study
32297828 2020. Correlation Between Relative Nasopharyngeal Virus RNA Load and Lymphocyte Count Disease Severity in Patients with COVID-19
32370466 2020. Characteristics of peripheral blood leukocyte differential counts in patients with COVID-19
32114745 2020. Characteristics of peripheral blood leukocyte differential counts in patients with COVID-19
32377375 2020. Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing
32361250 2020. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients
| 32376308 2020. Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis |
t cell exhaustion
32249845 ä. Fighting COVID-19 exhausts T cells
| 32203188 ä. Functional exhaustion of antiviral lymphocytes in COVID-19 patients |
| 32203186 ä. Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients |
| 32203188 2020. Functional exhaustion of antiviral lymphocytes in COVID-19 patients |
| 32203186 2020. Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients |
immunopathology
32371101 ä. The correlation between SARS-CoV-2 infection and rheumatic disease
32205186 2020. COVID-19 infection and rheumatoid arthritis: Faraway, so close!
32308263 2020. CoViD-19 Immunopathology and Immunotherapy
32320677 ä. Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure
32161940 ä. Dysregulation of immune response in patients with COVID-19 in Wuhan, China
32282863 ä. Molecular immune pathogenesis and diagnosis of COVID-19
32321823 2020. COVID-19: an Immunopathological View
32273594 ä. COVID-19: immunopathology and its implications for therapy
32303696 ä. Macrophages: a Trojan horse in COVID-19?
| 32376901 ä. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages |
antiviral immune response
32280952 ä. Good IgA bad IgG in SARS-CoV-2 infection?
32353870 2020. The many faces of the anti-COVID immune response
32358956 ä. Longitudinal Change of SARS-Cov2 Antibodies in Patients with COVID-19
31981224 2020. Coronavirus infections and immune responses
32198005 2020. A case of COVID-19 and pneumonia returning from Macau in Taiwan: Clinical course and anti-SARS-CoV-2 IgG dynamic
32284614 ä. Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19
32355329 ä. SARS-CoV-2-reactive T cells in patients and healthy donors
32346091 ä. Neutralizing antibody response in mild COVID-19
32356908 2020. Mathematical modeling of interaction between innate and adaptive immune responses in COVID-19 and implications for viral pathogenesis
| 32343415 2020. Long-term coexistence of SARS-CoV-2 with antibody response in COVID-19 patients |
32330332 2020. SARS-CoV-2 infection in children - Understanding the immune responses and controlling the pandemic
32267987 2020. Immune responses and pathogenesis of SARS?CoV?2 during an outbreak in Iran: Comparison with SARS and MERS
32348715 2020. B Cells, Viruses, and the SARS-CoV-2/COVID-19 Pandemic of 2020
32382126 ä. Protective humoral immunity in SARS-CoV-2 infected pediatric patients
32200654 2020. Time Kinetics of Viral Clearance and Resolution of Symptoms in Novel Coronavirus Infection
secondary autoimmunity
32292901 2020. Pathogenic priming likely contributes to serious and critical illness and mortality in COVID-19 via autoimmunity
32220633 2020. Could Sars-coronavirus-2 trigger autoimmune and/or autoinflammatory mechanisms in genetically predisposed subjects?
32315487 2020. Clinical and Autoimmune Characteristics of Severe and Critical Cases of COVID-19
| 32314313 2020. Is COVID-19 a proteiform disease inducing also molecular mimicry phenomena? |
32389543 ä. COVID-19 and molecular mimicry: The Columbus? egg?
Thymus
32340873 ä. Reply: Thymopoiesis, inflamm-aging, and COVID-19 phenotype
32317217 ä. Role of thymopoiesis and inflamm-aging in COVID-19 phenotype
Eosinopenia, Eosinophilia
32368728 ä. Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: a retrospective case-control study
32344056 ä. Eosinophil Responses During COVID-19 Infections and Coronavirus Vaccination
32369190 2020. COVID-19, chronic inflammatory respiratory diseases and eosinophils - Observationsfrom reported clinical case series
| 32315429 ä. Eosinophil count in severe coronavirus disease 2019 (COVID-19) |
32315421 ä. Response letter to Eosinophil count in severe coronavirus disease 2019 (COVID-19)
Immunogenetics
32303592 2020. Human leukocyte antigen susceptibility map for SARS-CoV-2
32343152 2020. ABO blood group predisposes to COVID-19 severity and cardiovascular diseases
007
32454497 2020. COVID-19 and Nasal Cytobrush Cytology.
32437316 2020. Pathology and Pathogenesis of SARS-CoV-2 Associated with Fatal Coronavirus Disease, United States.
32412897 2020. Clinicopathologic and Immunohistochemical Findings from Autopsy of Patient with COVID-19, Japan.
32476607 2020. Delayed specific IgM antibody responses observed among COVID-19 patients with severe progression.
32475230 2020. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors.
32471334 2020. Particulate multivalent presentation of the receptor binding domain induces protective immune responses against MERS-CoV.
32496247 2020. Genome analysis of SARS-CoV-2 isolates occurring in India: Present scenario.
32393680 2020. Incomplete Kawasaki Disease in a Child with Covid-19.
32423095 2020. The Expression and Polymorphism of Entry Machinery for COVID-19 in Human: Juxtaposing Population Groups, Gender, and Different Tissues.
32397174 2020. Cytokine Release Syndrome in COVID-19 Patients, A New Scenario for an Old Concern: The Fragile Balance between Infections and Autoimmunity.
32463803 2020. Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent.
32459663 2020. COVID-19, microangiopathy, hemostatic activation, and complement.
32217834 2020. SARS-CoV-2: a storm is raging.
32486469 2020. COVID-19 Related Coagulopathy: A Distinct Entity?
32466577 2020. Early Phylogenetic Diversification of SARS-CoV-2: Determination of Variants and the Effect on Epidemiology, Immunology, and Diagnostics.
32422996 2020. Highly Conserved Homotrimer Cavity Formed by the SARS-CoV-2 Spike Glycoprotein: A Novel Binding Site.
32403217 2020. Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence.
32492165 2020. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
32427582 2020. Clinical and pathological investigation of severe COVID-19 patients.
32501293 2020. Longitudinal COVID-19 profiling associates IL-1Ra and IL-10 with disease severity and RANTES with mild disease.
32492292 2020. Two hits to the renin-angiotensin system may play a key role in severe COVID-19.
32484232 2020. Radiologisk och histologisk bild for en okad forstaelse vid covid-19.
32475810 2020. The role of biomarkers in diagnosis of COVID-19 - A systematic review.
32471829 2020. Novel Immunoglobulin Domain Proteins Provide Insights into Evolution and Pathogenesis of SARS-CoV-2-Related Viruses.
32512290 2020. Expression of angiotensin-converting enzyme 2 and proteases in COVID-19 patients: A potential role of cellular FURIN in the pathogenesis of SARS-CoV-2.
32512491 2020. COVID-19-related complications and decompression illness share main features.: Could the SARS-CoV2-related complications rely on blood foaming?
32499358 2020. Complete Genome Sequence of a SARS-CoV-2 Strain Isolated in Northern Germany.
32401000 2020. First ultrastructural autoptic findings of SARS-Cov-2 in olfactory pathways and brainstem.
32483236 2020. Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients.
32512569 2020. COVID-19 Attacks the Kidney: Ultrastructural Evidence for the Presence of Virus in the Glomerular Epithelium.
32418306 2020. Comment on Matricardi PM et al: The first, holistic immunological model of COVID-19: Implications for prevention, diagnosis, and public health measures.
32462467 2020. Covid-19 and Kawasaki Disease: A Glimpse at the Past for a Predictable Future.
32397896 2020. Placental Pathology in Covid-19 Positive Mothers: Preliminary Findings.
32437232 2020. Virus-induced genetics revealed by multidimensional precision medicine transcriptional workflow applicable to COVID-19.
32469225 2020. COVID-19 and the immune system.
32511245 2020. A unifying structural and functional model of the coronavirus replication organelle: Tracking down RNA synthesis.
32437478 2020. Harnessing the natural anti-glycan immune response to limit the transmission of enveloped viruses such as SARS-CoV-2.
32449333 2020. Ability of the immune system to fight viruses highlighted by cytometry and TCR clonotype assessments: lessons taken prior to COVID-19 virus pandemic outbreak.
32439706 2020. Reply to Sanchez-Pacheco et al., Chookajorn, and Mavian et al.: Explaining phylogenetic network analysis of SARS-CoV-2 genomes.
32436320 2020. The role of SARS-CoV-2 antibodies in COVID-19: Healing in most, harm at times.
32428139 2020. Hematological changes in Covid-19 infections.
32404436 2020. TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes.
32507360 2020. Delirium, sleep, COVID-19 and melatonin.
32436629 2020. High COVID-19 virus replication rates, the creation of antigen-antibody immune complexes and indirect haemagglutination resulting in thrombosis.
32507543 2020. Spiking Pandemic Potential: Structural and Immunological Aspects of SARS-CoV-2.
32421281 2020. Is there relationship between SARS-CoV 2 and the complement C3 and C4?
32496734 2020. The effects of blood group types on the risk of COVID-19 infection and its clinical outcome.
32438622 2020. Dynamics of Population Immunity Due to the Herd Effect in the COVID-19 Pandemic.
32423059 2020. Recent Insight into SARS-CoV2 Immunopathology and Rationale for Potential Treatment and Preventive Strategies in COVID-19.
32422894 2020. A Novel Synonymous Mutation of SARS-CoV-2: Is This Possible to Affect Their Antigenicity and Immunogenicity?
32482591 2020. Swine enteric alphacoronavirus (swine acute diarrhea syndrome coronavirus): An update three years after its discovery.
32503352 2020. Genomic Sequencing and Analysis of Eight Camel-Derived Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Isolates in Saudi Arabia.
32485101 2020. Vascular Endothelial Growth Factor (VEGF) as a Vital Target for Brain Inflammation during the COVID-19 Outbreak.
32420946 2020. COVID-19 and food allergy in children.
32430094 2020. The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection.
32451547 2020. APOE e4 genotype predicts severe COVID-19 in the UK Biobank community cohort.
32423917 2020. COVID-19 as an Acute Inflammatory Disease.
32463092 2020. Multisystem Inflammatory Syndrome in Children during the COVID-19 pandemic: a case series.
32441749 2020. COVID-19 Associated Pediatric Multi-System Inflammatory Syndrome.
32478523 2020. Comparing the Binding Interactions in the Receptor Binding Domains of SARS-CoV-2 and SARS-CoV.
32461321 2020. Porcine epidemic diarrhea virus deficient in RNA cap guanine-N-7 methylation is attenuated and induces higher type I and III interferon responses.
32461317 2020. Porcine Deltacoronavirus nsp5 Cleaves DCP1A to Decrease Its Antiviral Ability.
32434888 2020. Replication of SARS-CoV-2 in human respiratory epithelium.
32404529 2020. Comparison of SARS-CoV-2 spike protein binding to ACE2 receptors from human, pets, farm animals, and putative intermediate hosts.
32391855 2020. COVID-19 and Postinfection Immunity: Limited Evidence, Many Remaining Questions.
32511692 2020. Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2.
32511676 2020. Multisystem Inflammatory Syndrome Related to COVID-19 in Previously Healthy Children and Adolescents in New York City.
32511667 2020. SARS-CoV-2-Related Inflammatory Multisystem Syndrome in Children: Different or Shared Etiology and Pathophysiology as Kawasaki Disease?
32424314 2020. SARS-CoV-2 causes COVID-19-like disease in cynomolgus macaques.
32504757 2020. Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to Macrophage Activation Syndrome: Therapeutic implications.
32504754 2020. Is melatonin deficiency a unifying pathomechanism of high risk patients with COVID-19?
32512289 2020. Neutralizing antibodies mediate virus-immune pathology of COVID-19.
32505911 2020. Antibiotic consumption may be linked to exaggeration of COVID-19.
32485313 2020. MDA5 should be detected in severe COVID-19 patients.
32506536 2020. Emerging viral mutants in Australia suggest RNA recombination event in the SARS-CoV-2 genome.
32490726 2020. Thromboinflammatory response in SARS-CoV-2 sepsis.
32407057 2020. Peripheral lymphocyte subset monitoring in COVID19 patients: a prospective Italian real-life case series.
32407507 2020. Genomic epidemiology, evolution, and transmission dynamics of porcine deltacoronavirus.
32437597 2020. Covid-19, Angiogenesis, and ARDS Endotypes.
32437596 2020. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.
32504046 2020. Implications of antibody-dependent enhancement of infection for SARS-CoV-2 countermeasures.
32405028 2020. Infection of bat and human intestinal organoids by SARS-CoV-2.
32398875 2020. Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19.
32454513 2020. Human neutralizing antibodies elicited by SARS-CoV-2 infection.
32454512 2020. A human neutralizing antibody targets the receptor binding site of SARS-CoV-2.
32438371 2020. Structure of replicating SARS-CoV-2 polymerase.
32408338 2020. Pathogenesis and transmission of SARS-CoV-2 in golden hamsters.
32396922 2020. Respiratory disease in rhesus macaques inoculated with SARS-CoV-2.
32469258 2020. Detection of SARS-CoV-2 in Human Retinal Biopsies of Deceased COVID-19 Patients.
32423291 2020. Association Between COVID-19 and Kawasaki Disease: Vigilance Required From Otolaryngologists.
32510562 2020. Long-term and herd immunity against SARS-CoV-2: implications from current and past knowledge.
32467454 2020. Covid-19 and Kawasaki Disease: An Etiology or Coincidental Infection?
32492695 2020. Does the newly observed inflammatory syndrome in children demonstrate a link between uncontrolled neutrophil extracellular traps formation and COVID-19?
32439816 2020. SARS-CoV-2-Induced Kawasaki-Like Hyperinflammatory Syndrome: A Novel COVID Phenotype in Children.
32456506 2020. Hemostatic laboratory derangements in COVID-19 with a focus on platelet count.
32397915 2020. Platelet functions and activities as potential hematologic parameters related to Coronavirus Disease 2019 (Covid-19).
32503918 2020. Enhanced receptor binding of SARS-CoV-2 through networks of hydrogen-bonding and hydrophobic interactions.
32401447 2020. Quels liens entre le SARS-CoV-2 et la maladie de Kawasaki ?
32348061 2020. COVID-19, une maladie endotheliale ?
32502331 2020. Comparison of confirmed COVID-19 with SARS and MERS cases - Clinical characteristics, laboratory findings, radiographic signs and outcomes: A systematic review and meta-analysis.
32467379 2020. The search for a COVID-19 animal model.
32299928 2020. From mice to monkeys, animals studied for coronavirus answers.
32433216 2020. Serum Hydrogen Sulfide and Outcome Association in Pneumonia by the SARS-CoV-2 Corona virus.
32482825 2020. Testing animals for SARS-CoV-2.
32490723 2020. Development of a TaqMan-probe-based multiplex real-time PCR for the simultaneous detection of emerging and reemerging swine coronaviruses.
32496715 2020. [Etiology of epidemic outbreaks COVID-19 on Wuhan, Hubei province, Chinese People Republic associated with 2019-nCoV (Nidovirales, Coronaviridae, Coronavirinae, Betacoronavirus, Subgenus Sarbecovirus): lessons of SARS-CoV outbreak.]
32391668 2020. [Dynamic inflammatory response in a critically ill COVID-19 patient treated with corticosteroids].
32392945 2020. [Comparison of pathological changes and pathogenic mechanisms caused by H1N1 influenza virus, highly pathogenic H5N1 avian influenza virus, SARS-CoV, MERS-CoV and 2019-nCoV].
32213267 2020. [Interpretation of pathological changes for "Guidelines for the Diagnosis and Treatment of COVID-19 by the National Health Commission (Trial Version 7) "].
32486534 2020. [Pathological changes of fatal coronavirus disease 2019 (COVID-19) in the lungs: report of 10 cases by postmortem needle autopsy].
32241072 2020. [Comparison of clinical and pathological features between severe acute respiratory syndrome and coronavirus disease 2019].
32455515 2020. [Clinical feature changes of a COVID-19 patient from mild to critical condition and cardiopulmonary pathological results].
32444414 2020. Antibodies against immunogenic epitopes with high sequence identity to SARS-CoV-2 in patients with autoimmune dermatomyositis.
32455617 2020. Novel Dynamic Structures of 2019-nCoV with Nonlocal Operator via Powerful Computational Technique.
32418947 2020. Does immune privilege result in recovered patients testing positive for COVID-19 again?
32493739 2020. Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study.
32467125 2020. Morphology of COVID-19-affected cells in peripheral blood film.
32453863 2020. COVID-19 and ABO blood group: another viewpoint.
32453859 2020. Clinical significance of blue-green neutrophil and monocyte cytoplasmic inclusions in SARS-CoV-2 positive critically ill patients.
32433784 2020. High-fluorescent lymphocytes are increased in patients with COVID-19.
32420613 2020. Atypical lymphocytes in peripheral blood of patients with COVID-19.
32420610 2020. Temporal changes in immune blood cell parameters in COVID-19 infection and recovery from severe infection.
32462701 2020. Animal models of mechanisms of SARS-CoV-2 infection and COVID-19 pathology.
32512133 2020. Poor-sleep is associated with slow recovery from lymphopenia and an increased need for ICU care in hospitalized patients with COVID-19: A retrospective cohort study.
32458561 2020. Lymphopenia in COVID-19: Therapeutic opportunities.
32443810 2020. A Structural View of SARS-CoV-2 RNA Replication Machinery: RNA Synthesis, Proofreading and Final Capping.
32498376 2020. Neutrophils and Neutrophil Extracellular Traps Drive Necroinflammation in COVID-19.
32393592 2020. Cytokine storm and the prospects for immunotherapy with COVID-19.
32493734 2020. New spectrum of COVID-19 manifestations in children: Kawasaki-like syndrome and hyperinflammatory response.
32511972 2020. C-reactive protein: A promising biomarker for poor prognosis in COVID-19 infection.
32511971 2020. Comparative analysis of laboratory indexes of severe and non-severe patients infected with COVID-19.
32508038 2020. Can routine laboratory tests discriminate SARS-CoV-2-infected pneumonia from other causes of community-acquired pneumonia?
32508022 2020. Acute lung injury in patients with COVID-19 infection.
32490934 2020. Ultrasound-guided minimally invasive autopsies: A protocol for the study of pulmonary and systemic involvement of COVID-19.
32503659 2020. Body temperature correlates with mortality in COVID-19 patients.
32503382 2020. Biomarkers associated with COVID-19 disease progression.
32452762 2020. SARS-CoV-2 strategically mimics proteolytic activation of human ENaC.
32428990 2020. The role of interleukin-6 in monitoring severe case of coronavirus disease 2019.
32384045 2020. Prognostic Value of Leukocytosis and Lymphopenia for Coronavirus Disease Severity.
32459984 2020. SARS-CoV-2 Phylogenetic Analysis, Lazio Region, Italy, February-March 2020.
32507410 2020. The influenza virus, SARS-CoV-2, and the airways: Clarification for the otorhinolaryngologist.
32507608 2020. Hepatic consequences of COVID-19 infection. Lapping or biting?
32427393 2020. Telomeres and COVID-19.
32428379 2020. Understanding SARS-CoV-2 endocytosis for COVID-19 drug repurposing.
32505742 2020. Gastrointestinal symptoms as a major presentation component of a novel multisystem inflammatory syndrome in children (MIS-C) that is related to COVID-19: a single center experience of 44 cases.
32443177 2020. Pulmonary and systemic involvement of COVID-19 assessed by ultrasound-guided minimally invasive autopsy.
32424945 2020. Distribution of HLA allele frequencies in 82 Chinese individuals with coronavirus disease-2019 (COVID-19).
32460357 2020. Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China.
32512089 2020. Corona virus versus existence of human on the earth: A computational and biophysical approach.
32470223 2020. COVID-19: Structural Predictions of Viral Success.
32441844 2020. Involvement of ADAMTS13 and von Willebrand factor in thromboembolic events in patients infected with SARS-CoV-2.
32512386 2020. Proteolytic Cleavage of the SARS-CoV-2 Spike Protein and the Role of the Novel S1/S2 Site.
32410502 2020. First comprehensive computational analysis of functional consequences of TMPRSS2 SNPs in susceptibility to SARS-CoV-2 among different populations.
32397951 2020. The expression level of angiotensin-converting enzyme 2 determines the severity of COVID-19: lung and heart tissue as targets.
32437018 2020. TMPRSS2: Potential Biomarker for COVID-19 Outcomes.
32455505 2020. Erythema multiforme and Kawasaki disease associated with COVID-19 infection in children.
32508068 2020. Defining Association between COVID-19 and the Multisystem Inflammatory Syndrome in Children through the Pandemic.
32470153 2020. Characteristics of inflammatory factors and lymphocyte subsets in patients with severe COVID-19.
32470148 2020. Serum KL-6 concentrations as a novel biomarker of severe COVID-19.
32462705 2020. Clinical features, isolation, and complete genome sequence of severe acute respiratory syndrome coronavirus 2 from the first two patients in Vietnam.
32458459 2020. Neutrophil to lymphocyte ratio as prognostic and predictive factor in patients with coronavirus disease 2019: A retrospective cross-sectional study.
32479682 2020. Preeclampsia-like syndrome induced by severe COVID-19: a prospective observational study.
32423901 2020. How covid-19 is accelerating the threat of antimicrobial resistance.
32414749 2020. Covid-19: Cases of inflammatory syndrome in children surge after urgent alert.
32493704 2020. Pediatric inflammatory syndrome temporally related to covid-19.
32420607 2020. The association between severe COVID-19 and low platelet count: evidence from 31 observational studies involving 7613 participants.
32495372 2020. Terminal complement inhibition dampens the inflammation during COVID-19.
32497257 2020. A lesson from a saboteur: high molecular weight kininogen (HMWK) impact in COVID-19.
32484220 2020. Discovery of G-quadruplex-forming sequences in SARS-CoV-2.
32444466 2020. The Landscape of Human Cancer Proteins Targeted by SARS-CoV-2.
32412400 2020. Covid-19 and Kawasaki syndrome: should we really be surprised?
32420587 2020. COVID-19 as a cardiovascular disease: the potential role of chronic endothelial dysfunction.
32467617 2020. Serum IgA, IgM, and IgG responses in COVID-19.
32467616 2020. More bricks in the wall against SARS-CoV-2 infection: involvement of gamma9delta2 T cells.
32484450 2020. Urinalysis parameters for predicting severity in coronavirus disease 2019 (COVID-19).
32504637 2020. Elevated monocyte distribution width in COVID-19 patients: The contribution of the novel sepsis indicator.
32463434 2020. Metatranscriptomic Characterization of COVID-19 Identified A Host Transcriptional Classifier Associated With Immune Signaling.
32445579 2020. Prognostic value of C-reactive protein in patients with COVID-19.
32497196 2020. Neutralizing Antibodies Responses to SARS-CoV-2 in COVID-19 Inpatients and Convalescent Patients.
32497191 2020. Alterations of the Gut Microbiota in Patients with COVID-19 or H1N1 Influenza.
32390402 2020. SARS-CoV-2 and Eosinophilia.
32414743 2020. Procalcitonin for patient stratification and identification of bacterial co-infection in COVID-19.
32506725 2020. Dengue Fever, COVID-19 (SARS-CoV-2), and Antibody-Dependent Enhancement (ADE): A Perspective.
32488957 2020. Procedures for Flow Cytometry-Based Sorting of Unfixed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infected Cells and Other Infectious Agents.
32430459 2020. Exploring Diseases/Traits and Blood Proteins Causally Related to Expression of ACE2, the Putative Receptor of SARS-CoV-2: A Mendelian Randomization Analysis Highlights Tentative Relevance of Diabetes-Related Traits.
32418550 2020. Are Iranian Sulfur Mustard Gas-Exposed Survivors More Vulnerable to SARS-CoV-2? Some Similarity in Their Pathogenesis.
32501877 2020. Kinetic patterns of liver enzyme elevation with COVID-19 in the USA.
32460534 2020. C3 and ACE1 polymorphisms are more important confounders in the spread and outcome of COVID-19 in comparison with ABO polymorphism.
32412405 2020. Understanding the cytokine storm during COVID-19: Contribution of preexisting chronic inflammation.
32460624 2020. The amount of cytokine-release defines different shades of Sars-Cov2 infection.
32472763 2020. Comparative analysis of Coronaviridae nucleocapsid and surface glycoprotein sequences.
32393819 2020. COVID-19 outcomes and the human genome.
32475052 2020. Binding affinities of 438 HLA proteins to complete proteomes of seven pandemic viruses and distributions of strongest and weakest HLA peptide binders in populations worldwide.
32404331 2020. COVID-19 and Kawasaki Disease: Finding the Signal in the Noise.
32426999 2020. Gnotobiotic Rats Reveal That Gut Microbiota Regulates Colonic mRNA of Ace2, the Receptor for SARS-CoV-2 Infectivity.
32503824 2020. Endoplasmic Reticulum Stress Markers in SARS-COV-2 Infection and Pneumonia: Case-Control Study.
32503822 2020. Human Gene Sequences in SARS-CoV-2 and Other Viruses.
32503821 2020. SARS-CoV-2 orf1b Gene Sequence in the NTNG1 Gene on Human Chromosome 1.
32474554 2020. Mapping the genomic landscape & diversity of COVID-19 based on >3950 clinical isolates of SARS-CoV-2: Likely origin & transmission dynamics of isolates sequenced in India.
32474553 2020. Analysis of RNA sequences of 3636 SARS-CoV-2 collected from 55 countries reveals selective sweep of one virus type.
32462354 2020. Multisystem Inflammatory Syndrome with Features of Atypical Kawasaki Disease during COVID-19 Pandemic.
32485332 2020. SARS-CoV-2 Molecular and Phylogenetic analysis in COVID-19 patients: A preliminary report from Iran.
32468151 2020. The unleashing of the immune system in COVID-19 and sepsis: the calm before the storm?
32468052 2020. Pancancer analysis of transmembrane protease serine 2 and cathepsin L that mediate cellular SARSCoV2 infection leading to COVID-19.
32456409 2020. A theory on SARS-COV-2 susceptibility: reduced TLR7-activity as a mechanistic link between men, obese and elderly.
32476380 2020. SARS-CoV-2, which induces COVID-19, causes kawasaki-like disease in children: role of pro-inflammatory and anti-inflammatory cytokines.
32490733 2020. Interleukin 6 polymorphisms as an indicator of COVID-19 severity in humans.
32434769 2020. Viropathic multinuclear syncytial giant cells in bronchial fluid from a patient with COVID-19.
32401043 2020. Conserved High Free Energy Sites in Human Coronavirus Spike Glycoprotein Backbones.
32493814 2020. Inflammasomes and Pyroptosis as Therapeutic Targets for COVID-19.
32493812 2020. Role of Aging and the Immune Response to Respiratory Viral Infections: Potential Implications for COVID-19.
32474608 2020. Decreased B cells on admission was associated with prolonged viral RNA shedding from respiratory tract in Coronavirus Disease 2019: a case control study.
32433742 2020. Extended ORF8 Gene Region Is Valuable in the Epidemiological Investigation of SARS-similar Coronavirus.
32506640 2020. Viral Infections and Their Relationship with Catastrophic Antiphospholipid Syndrome: A Possible Pathogenic Mechanism of Severe COVID-19 Thrombotic Complications.
32472706 2020. The Long-Standing History of Corynebacterium Parvum, Immunity and Viruses.
32470151 2020. The perplexing question of trained immunity versus adaptive memory in COVID-19.
32497323 2020. Increasing Host Cellular Receptor-Angiotensin-Converting Enzyme 2 (ACE2) Expression by Coronavirus may Facilitate 2019-nCoV (or SARS-CoV-2) Infection.
32497295 2020. Comment on "Genetic variants and source of introduction of SARS-CoV-2 in South America".
32492206 2020. Understanding the possible origin and genotyping of first Bangladeshi SARS-CoV-2 strain.
32492203 2020. Structural variations and expression profiles of the SARS-CoV-2 host invasion genes in Lung cancer.
32492196 2020. High-Coverage SARS-CoV-2 Genome Sequences Acquired by Target Capture Sequencing.
32492195 2020. Functional prediction and frequency of coding variants in human ACE2 at binding sites with SARS-CoV-2 spike protein on different populations.
32492183 2020. Evidence for mutations in SARS-CoV-2 Italian isolates potentially affecting virus transmission.
32478897 2020. Conditional cell reprogramming for modeling host-virus interactions and human viral diseases.
32501810 2020. ACE2 and TMPRSS2 variants and expression as candidates to sex and country differences in COVID-19 severity in Italy.
32484453 2020. Infection with SARS-CoV-2 causes abnormal laboratory results of multiple organs in patients.
32413176 2020. The emergence of methemoglobinemia amidst the COVID-19 pandemic.
32510973 2020. Decoding SARS-CoV-2 Hijacking of Host Mitochondria in Pathogenesis of COVID-19.
32469255 2020. SARS-CoV-2 perturbs the Renin-Angiotensin System and energy metabolism.
32501731 2020. Cholesterol: A new game player accelerating endothelial injuries caused by SARS-CoV-2?
32493030 2020. Thoughts on the alveolar phase of COVID-19.
32504123 2020. COVID-19 research: toxicological input urgently needed!
32420944 2020. The impact of MicroRNAs (miRNAs) on the genotype of coronaviruses.
32420938 2020. What happens to people's lungs when they get coronavirus disease 2019?
32506059 2020. Detection of Hemosiderin-Laden Macrophages in Bronchoalveolar Lavage Fluid of COVID-19 Patients: Is Perls Stain a Potential Indicator of Oxidative Alveolar Damage?
32496587 2020. Distribution of ACE2, CD147, CD26 and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors.
32451533 2020. Molecular Detection of SARS-CoV-2 Infection in FFPE Samples and Histopathologic Findings in Fatal SARS-CoV-2 Cases.
32441303 2020. Placental Pathology in COVID-19.
32472588 2020. Increased sFLT1/PlGF ratio in COVID-19: a novel link to Angiotensin II-mediated endothelial dysfunction.
32491212 2020. Circulating endothelial cells in COVID-19.
32479159 2020. Related molecular mechanisms of COVID-19, hypertension, and diabetes.
32437622 2020. Complement Activation During Critical Illness: Current Findings and an Outlook in the Era of COVID-19.
32432483 2020. Expression of the SARS-CoV-2 ACE2 Receptor in the Human Airway Epithelium.
32412787 2020. Bronchoscopy in COVID-19 Patients with Invasive Mechanical Ventilation: A Center Experience.
32410724 2020. The Lungs before and after COVID-19 Pneumonia.
32422081 2020. Autopsy Report with Clinical Pathological Correlation.
32510978 2020. Overcoming Barriers: The Endothelium As a Linchpin of Coronavirus Disease 2019 Pathogenesis?
32470119 2020. Coronavirus3D: 3D structural visualization of COVID-19 genomic divergence.
32418446 2020. Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic.
32386190 2020. Erythrocyte sedimentation rate is associated with severe coronavirus disease 2019 (COVID-19): a pooled analysis.
32459190 2020. Low levels of total and ionized calcium in blood of COVID-19 patients.
32441666 2020. Dynamic profile and clinical implications of hematological parameters in hospitalized patients with coronavirus disease 2019.
some other papers
32215589 2020. Antibodies in Infants Born to Mothers With COVID-19 Pneumonia
32360743 ä. Lower detection rates of SARS-COV2 antibodies in cancer patients vs healthcare workers after symptomatic COVID-19
32292530 2020. Respiratory diseases, allergy and COVID-19 infection. First news from Wuhan
32346093 ä. The trinity of COVID-19: immunity, inflammation and intervention
32348636 2020. Hyposalivation as a potential risk for SARS-CoV-2 infection: Inhibitory role of saliva
32297330 2020. Reactive lymphocytes in patients with Covid-19
32311762 2020. SARS-CoV-2: a new aetiology for atypical lymphocytes
| 32156572 2020. Viroporins and inflammasomes: A key to understand virus-induced inflammation |
32235915 ä. COVID-19: a new challenge for human beings
| 32359201 2020. The first, holistic immunological model of COVID-19: implications for prevention, diagnosis, and public health measures |
| 32073157 2020. Antibodies to coronaviruses are higher in older compared with younger adults and binding antibodies are more sensitive than neutralizing antibodies in identifying coronavirus?associated illnesses |
32376309 2020. Viral kinetics of SARS-CoV-2 in asymptomatic carriers and presymptomatic patients
32132669 ä. Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV
32388390 2020. The powerful immune system against powerful COVID-19: A hypothesis
32372807 2020. The fever paradox
32372779 2020. Do you become immune once you have been infected?
